Forbes India58m
Explained: How Trump's tariffs will impact Indian pharma industry, US health care
Low-margin, generic-focussed Indian players will be more affected; increasing costs will be impact patients in the US ...
Live Mint on MSN42m
Why Tariff Cuts Will Make American Whiskeys Like Jim Beam Cheaper, But WON'T Benefit Jack Daniels
The cut in import duties on bourbon whiskey, which were notified ahead of the recent meeting between Prime Minister Narendra ...
Indian drugmakers likely to stay competitive as US tariffs loom, Dr Reddy’s says
Indian drugmakers are likely to remain competitive in the generics market even as U.S. President Donald Trump's plans to levy tariffs on pharmaceutical imports, ...
Mid & small-caps could face further pressure; large-caps show potential for gradual growth: Jitendra Gohil
Overall Nifty earnings should stabilise going forward. So, we are of the opinion that Nifty 50 index if I look at the ...